Clinical trial
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric…
NCT00048854 · Yale University, Other · Completed
Key facts
| NCT number | NCT00048854 |
|---|---|
| Title | Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder |
| Official title | Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Premenstrual Syndrome |
| Intervention type | Drug, Other |
| Interventions | Sertraline, Treatment as usual (TAU) |
| Enrollment | 66 |
| Start date | Sep 1, 2001 |
| Primary completion | Jun 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Nov 13, 2002 |
| Last update posted | Jan 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: